e-Drug3D

288

TRANYLCYPROMINE


INN
TRANYLCYPROMINE

cas 155-09-9
CLASS

NERVOUS SYSTEM
ANTIDEPRESSANT
ANTI-ANXIETY AGENTS
MONOAMINE OXIDASE (MAO) INHIBITORS

ROUTE (list)

ORAL

ATC code

N06AF04

PK parameters

Tmax 1 HOUR (PMID3757407)
Cl 63.4 LITER / HOUR
t1/2 1.58 HOUR

Target

TARGET MONOAMINE OXIDASE MAO

PDB
3MDR (TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1)

Ligand code = GJZ (link to the list of PDB complexes)

Download experimental 3D coordinates of GJZ with added hydrogens

DrugCentral

Amine oxidase flavin-containing B UNIPROT P27338 MAOB

Download SDF file (1R)-2-phenylcyclopropan-1-amine

Formula:
C9H11N

Calculated chemical properties:

MW 133.19
NB_atoms 10
XLogP 1.50
PSA 25.536
NB_HD 2
NB_HA 1
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 012342 (pdf not found) INN (TRANYLCYPROMINE SULFATE) PARNATE (ADVANZ PHARMA) APPROVAL= AP YEAR= 1961
NDA 040640 (pdf not found) INN (TRANYLCYPROMINE SULFATE) TRANYLCYPROMINE SULFATE (STRIDES PHARMA) APPROVAL= AP YEAR= 2006
NDA 206856 (pdf not found) INN (TRANYLCYPROMINE SULFATE) TRANYLCYPROMINE SULFATE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2018
NDA 213503 (pdf not found) INN (TRANYLCYPROMINE SULFATE) TRANYLCYPROMINE SULFATE (CROSSMEDIKA SA) APPROVAL= AP YEAR= 2022

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL